US Equity
ATNM
— ACTINIUM PHARMACEUTICALS, INC.Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing targeted radiotherapy treatments for cancer.
💰 Market cap: $26.81M📍 100 Park Ave., 23Rd Floor, NEW YORK, NY, 10017 US🏷️ Biotechnology & Medical Research💵 Previous close: $0.86🔢 3,438 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $0.86 |
| 2026-07-23 | $0.89 |
| 2026-07-22 | $0.90 |
| 2026-07-21 | $0.90 |
| 2026-07-20 | $0.88 |
| 2026-07-17 | $0.92 |
| 2026-07-16 | $0.89 |
| 2026-07-15 | $0.92 |
| 2026-07-14 | $0.90 |
| 2026-07-13 | $0.91 |
| 2026-07-10 | $0.93 |
| 2026-07-09 | $0.97 |
| 2026-07-08 | $0.97 |
| 2026-07-07 | $1.05 |
| 2026-07-06 | $0.96 |
| 2026-07-02 | $0.98 |
| 2026-07-01 | $0.98 |
| 2026-06-30 | $0.98 |
| 2026-06-29 | $0.99 |
| 2026-06-26 | $0.99 |
| 2026-06-25 | $0.95 |
| 2026-06-24 | $1.01 |
| 2026-06-23 | $1.02 |
| 2026-06-22 | $1.03 |
| 2026-06-18 | $1.03 |
| 2026-06-17 | $1.02 |
| 2026-06-16 | $0.98 |
| 2026-06-15 | $1.00 |
| 2026-06-12 | $1.01 |
| 2026-06-11 | $1.04 |
| 2026-06-10 | $1.05 |
| 2026-06-09 | $1.01 |
| 2026-06-08 | $1.06 |
| 2026-06-05 | $1.08 |
| 2026-06-04 | $1.11 |
| 2026-06-03 | $1.16 |
| 2026-06-02 | $1.22 |
| 2026-06-01 | $1.18 |
| 2026-05-29 | $1.26 |
| 2026-05-28 | $1.15 |
| 2026-05-27 | $1.18 |
| 2026-05-26 | $1.16 |
| 2026-05-22 | $1.18 |
| 2026-05-21 | $1.18 |
| 2026-05-20 | $1.17 |
| 2026-05-19 | $1.15 |
| 2026-05-18 | $1.17 |
| 2026-05-15 | $1.25 |
| 2026-05-14 | $1.28 |
| 2026-05-13 | $1.29 |
| 2026-05-12 | $1.30 |
| 2026-05-11 | $1.34 |
| 2026-05-08 | $1.31 |
| 2026-05-07 | $1.22 |
| 2026-05-06 | $1.24 |
| 2026-05-05 | $1.26 |
| 2026-05-04 | $1.20 |
| 2026-05-01 | $1.13 |
| 2026-04-30 | $1.11 |
| 2026-04-29 | $1.17 |
| 2026-04-28 | $1.19 |